High Outlier
Strength
61.25; 245 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710214201
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Authorized Generic (NDA)
FDA Application
NDA203312On Market Since
10/20/2025
Pharmacological Classes
Related Drugs
Same classification
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00093970201•Teva Pharmaceuticals USA Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00093970205•Teva Pharmaceuticals USA Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00093970210•Teva Pharmaceuticals USA Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00378008501•Mylan Pharmaceuticals Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
52817039100•TruPharma LLC
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
52817039110•TruPharma LLC
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
52817039150•TruPharma LLC
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
72888010700•Advagen Pharma Ltd.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
72888010701•Advagen Pharma Ltd.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
72888010705•Advagen Pharma Ltd.
$0.0724
per EA